Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recurrent GBM Stem Cell Tumor Amplified RNA Immunotherapy Trial

NCT00890032 is registered in ClinicalTrials.gov with John Sampson as lead sponsor.

NCT NCT00890032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00890032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recurrent GBM Stem Cell Tumor Amplified RNA Immunotherapy Trial
Lead sponsor
John Sampson
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2009
Completion date
February 29, 2016
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent central nervous system neoplasm